(UVV) Universal - Ratings and Ratios
Leaf Tobacco, Plant-Based Ingredients, Flavors, Extracts, Concentrates
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 7.70% |
| Yield on Cost 5y | 11.28% |
| Yield CAGR 5y | 1.27% |
| Payout Consistency | 97.6% |
| Payout Ratio | 50.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 23.8% |
| Value at Risk 5%th | 34.5% |
| Relative Tail Risk | -11.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.08 |
| Alpha | -2.65 |
| CAGR/Max DD | 0.21 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.359 |
| Beta | 0.141 |
| Beta Downside | 0.195 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.70% |
| Mean DD | 13.04% |
| Median DD | 13.47% |
Description: UVV Universal November 13, 2025
Universal Corporation (NYSE:UVV) is a B2B agriproducts firm that supplies leaf tobacco and a broad portfolio of plant-based ingredients to food, beverage, and consumer-packaged-goods manufacturers worldwide. Founded in 1886 and based in Richmond, Virginia, the company operates two primary segments: Tobacco Operations and Ingredients Operations.
The Tobacco Operations segment handles the full supply chain for flue-cured, burley, dark air-cured, and oriental leaf tobacco, offering value-added services such as custom blending, chemical and physical testing, reconstituted leaf manufacturing, just-in-time delivery, liquid nicotine, and recycling of tobacco waste. The Ingredients Operations segment produces specialty plant-based products-including fruit and vegetable juices, purees, nutraceutical extracts, natural flavors, and colors-catering to clean-label and health-focused consumer trends.
Key metrics and sector drivers to note: UVV reported FY 2023 revenue of roughly $2.2 billion with an adjusted EBITDA margin near 15%; the company’s exposure to the growing reduced-risk nicotine market offsets long-term declines in traditional cigarette volumes, while demand for natural food ingredients is being propelled by regulatory pressure for clean labeling and rising consumer preference for plant-based products. Additionally, the tobacco segment’s cash-flow stability is supported by long-term contracts with major cigarette manufacturers, whereas the ingredients segment benefits from a diversified end-market base that mitigates commodity price volatility.
For a deeper quantitative assessment, you may find ValueRay’s analyst tools useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (111.6m TTM) > 0 and > 6% of Revenue (6% = 179.2m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 11.84pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 47.23% (prev 46.98%; Δ 0.25pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 154.6m > Net Income 111.6m (YES >=105%, WARN >=100%) |
| Net Debt (1.11b) to EBITDA (189.5m) ratio: 5.83 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.70 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (25.2m) change vs 12m ago 1.87% (target <= -2.0% for YES) |
| Gross Margin 18.88% (prev 19.20%; Δ -0.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 97.69% (prev 95.23%; Δ 2.47pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.84 (EBITDA TTM 189.5m / Interest Expense TTM 80.0m) >= 6 (WARN >= 3) |
Altman Z'' 5.59
| (A) 0.46 = (Total Current Assets 2.24b - Total Current Liabilities 828.6m) / Total Assets 3.07b |
| (B) 0.39 = Retained Earnings (Balance) 1.19b / Total Assets 3.07b |
| (C) 0.05 = EBIT TTM 147.1m / Avg Total Assets 3.06b |
| (D) 0.94 = Book Value of Equity 1.47b / Total Liabilities 1.57b |
| Total Rating: 5.59 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.58
| 1. Piotroski 4.0pt |
| 2. FCF Yield 6.48% |
| 3. FCF Margin 5.26% |
| 4. Debt/Equity 0.81 |
| 5. Debt/Ebitda 5.83 |
| 6. ROIC - WACC (= 0.17)% |
| 7. RoE 7.65% |
| 8. Rev. Trend 36.24% |
| 9. EPS Trend 15.48% |
What is the price of UVV shares?
Over the past week, the price has changed by -0.75%, over one month by -0.08%, over three months by -3.96% and over the past year by +2.53%.
Is UVV a buy, sell or hold?
What are the forecasts/targets for the UVV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 78 | 47.9% |
| Analysts Target Price | 78 | 47.9% |
| ValueRay Target Price | 59.2 | 12.3% |
UVV Fundamental Data Overview December 26, 2025
P/E Trailing = 11.9212
P/S = 0.4441
P/B = 0.8992
Beta = 0.674
Revenue TTM = 2.99b USD
EBIT TTM = 147.1m USD
EBITDA TTM = 189.5m USD
Long Term Debt = 618.2m USD (from longTermDebt, last quarter)
Short Term Debt = 551.4m USD (from shortTermDebt, last quarter)
Debt = 1.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.11b USD (from netDebt column, last quarter)
Enterprise Value = 2.42b USD (1.32b + Debt 1.19b - CCE 88.7m)
Interest Coverage Ratio = 1.84 (Ebit TTM 147.1m / Interest Expense TTM 80.0m)
FCF Yield = 6.48% (FCF TTM 157.1m / Enterprise Value 2.42b)
FCF Margin = 5.26% (FCF TTM 157.1m / Revenue TTM 2.99b)
Net Margin = 3.74% (Net Income TTM 111.6m / Revenue TTM 2.99b)
Gross Margin = 18.88% ((Revenue TTM 2.99b - Cost of Revenue TTM 2.42b) / Revenue TTM)
Gross Margin QoQ = 18.54% (prev 19.19%)
Tobins Q-Ratio = 0.79 (Enterprise Value 2.42b / Total Assets 3.07b)
Interest Expense / Debt = 1.83% (Interest Expense 21.8m / Debt 1.19b)
Taxrate = 24.36% (11.2m / 46.0m)
NOPAT = 111.3m (EBIT 147.1m * (1 - 24.36%))
Current Ratio = 2.70 (Total Current Assets 2.24b / Total Current Liabilities 828.6m)
Debt / Equity = 0.81 (Debt 1.19b / totalStockholderEquity, last quarter 1.47b)
Debt / EBITDA = 5.83 (Net Debt 1.11b / EBITDA 189.5m)
Debt / FCF = 7.04 (Net Debt 1.11b / FCF TTM 157.1m)
Total Stockholder Equity = 1.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.64% (Net Income 111.6m / Total Assets 3.07b)
RoE = 7.65% (Net Income TTM 111.6m / Total Stockholder Equity 1.46b)
RoCE = 7.08% (EBIT 147.1m / Capital Employed (Equity 1.46b + L.T.Debt 618.2m))
RoIC = 4.25% (NOPAT 111.3m / Invested Capital 2.62b)
WACC = 4.08% (E(1.32b)/V(2.51b) * Re(6.53%) + D(1.19b)/V(2.51b) * Rd(1.83%) * (1-Tc(0.24)))
Discount Rate = 6.53% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 0.24%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈157.1m ; Y1≈103.2m ; Y5≈47.2m
Fair Price DCF = 37.21 (DCF Value 927.3m / Shares Outstanding 24.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 15.48 | EPS CAGR: -0.77% | SUE: N/A | # QB: 0
Revenue Correlation: 36.24 | Revenue CAGR: 3.93% | SUE: N/A | # QB: 0
EPS current Year (2026-03-31): EPS=4.70 | Chg30d=+0.250 | Revisions Net=+1 | Growth EPS=+0.0% | Growth Revenue=+0.0%
EPS next Year (2027-03-31): EPS=4.61 | Chg30d=+0.350 | Revisions Net=+1 | Growth EPS=-1.9% | Growth Revenue=+1.0%
Additional Sources for UVV Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle